Sino Biopharm, Sciwind Biosciences sign strategic deal
Sino Biopharmaceutical Limited announced on Thursday that it had signed an exclusive strategic cooperation agreement with Sciwind Biosciences, a biotech company researching innovative treatments based in Hangzhou, Zhejiang province. The deal will bring in a candidate drug of Sciwind Bioscience, which is expected to become China’s first Class-1 innovative drug for nebulized treatment of pediatric…